Marvin Blase, M.d., P.C.

Marvin Blase, M.D., P.C., a veteran-owned medical consulting firm based in Atlanta, Georgia, provides independent case reviews and medical consultant services to the Social Security Administration as a prime contractor, with 100% of its recent federal award footprint concentrated in SSA disability adjudication work.

The firm operates as a for-profit corporate entity specializing in psychiatric medicine and psychology expertise for disability claim evaluation. Work centers on independent medical case file reviews supporting SSA's Center of Disability Program Support and Office of Disability Determinations in the Southeast Region. Service delivery is firm fixed price, typically involving 1,650 to 2,000 independent case reviews per contract period, performed from the firm's Sandy Springs, Georgia location. The vendor has maintained an unbroken relationship with SSA since at least July 2021.

Customer concentration is absolute: the Social Security Administration accounts for 68 of the firm's 80 recent federal awards and $6.2 million of the $7.6 million combined potential value across all awards (85% of awards, 81% of dollars). The vendor operates exclusively as a prime contractor with no subcontract exposure. The firm's NAICS profile splits between Offices of Physicians, Mental Health Specialists (35 awards) and Offices of Physicians except Mental Health Specialists (21 awards), with PSC coding dominated by Medical–Medical/Psychiatric Consultation (38 awards) and Behavioral and Mental Health (27 awards).

Marvin Blase, M.D., P.C. holds multiple active BPAs with SSA. The five most recent awards in the source (spanning May 2022 through July 2026) are all BPA call orders valued between $140 thousand and $187 thousand, each carrying firm fixed price terms and ultimate completion dates extending from mid-2024 through mid-2027. The July 1, 2026 BPA call (most recent, $145,590) extends performance through June 30, 2027. Historical awards tracked in the source include a July 16, 2021 call order under Total Small Business set-aside ($149,721), a May 27, 2022 call order with no set-aside restriction ($182,344), a September 1, 2023 call order with no set-aside restriction ($187,700), a July 5, 2024 call order under Total Small Business set-aside ($140,869), and a September 25, 2025 call order with no set-aside restriction ($174,708). Activity is modest and flat — one award per year in 2022 through 2026 — with only $320 thousand in combined potential value from the two awards facing completion within the next twenty-four months, representing minimal recompete exposure.